Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,533 | 3,990 | 5,650 | 3,240 | 5,619 |
| TOTAL | $5,752 | $4,043 | $5,735 | $3,357 | $5,786 |
| Non-Current Assets | |||||
| PPE Net | 14 | 7 | N/A | N/A | 3 |
| TOTAL | $14 | $7 | $N/A | $N/A | $3 |
| Total Assets | $5,766 | $4,050 | $5,735 | $3,357 | $5,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 460 | 688 | 825 | 491 | 928 |
| Other current liabilities | 6,707 | 2,758 | 2,958 | 2,240 | 3,575 |
| TOTAL | $7,325 | $3,446 | $3,820 | $2,806 | $4,643 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,325 | $3,446 | $3,820 | $2,806 | $4,643 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 843 | 788 | 543 | 462 | N/A |
| Common Shares | 25 | 237 | 236 | 214 | 21 |
| Retained earnings | -66,517 | -60,637 | -59,217 | -56,433 | -55,744 |
| TOTAL | $-1,560 | $604 | $1,915 | $551 | $1,146 |
| Total Liabilities And Equity | $5,766 | $4,050 | $5,735 | $3,357 | $5,789 |